IDiyas

For the Inventor, By the Inventor

Nutley, NJ, United States of America

Peter Michael Wovkulich

USPTO Granted Patents = 30 

 

 

Average Co-Inventor Count = 4.3

ph-index = 6

Forward Citations = 154(Granted Patents)


Location History:

  • Nutley, NJ (US) (1981 - 2015)
  • Apalachin, NY (US) (2016)
  • New York, NY (US) (2017)

Company Filing History:

goldMedal29 out of 4,942 
 
Hoffmann-la Roche Inc.
 patents
silverMedal1 out of 1,177 
 
Takeda Pharmaceutical Company Limited
 patents

Years Active: 1981-2017

Loading Chart...
Loading Chart...
Loading Chart...
30 patents (USPTO):
1. 9580411 - Substituted sulfonamide compounds (2017-02-28),
2. 9353096 - Substituted phenylcarbamate compounds (2016-05-31),
3. 9334278 - Pyrrolo[2,3-B]pyrazines as SYK inhibitors (2016-05-10),
4. 8940741 - Inhibitors of bruton's tyrosine kinase (2015-01-27),
5. 8658646 - Pyrrolopyrazine kinase inhibitors (2014-02-25),
6. 8481540 - Inhibitors of bruton's tyrosine kinase (2013-07-09),
7. 8044213 - Thiazolyl-benzimidazoles (2011-10-25),
8. 8003785 - Halo-substituted pyrimidodiazepines (2011-08-23),
9. 7851626 - 4,4,5,5, tetrasubstituted imidazolines (2010-12-14),
10. 7615634 - 4-aminopyrimidine-5-one derivatives (2009-11-10),
11. 7524840 - 7,8-disubstituted pyrazolobenzodiazepines (2009-04-28),
12. 7423051 - 2,6-diaminopyridine derivatives (2008-09-09),
13. 7157455 - 4-Aminopyrimidine-5-one derivatives (2007-01-02),
14. 6916923 - Method for synthesizing pyrazolobenzodiazepines (2005-07-12),
15. 6838558 - Pyrazolobenzodiazepines (2005-01-04),

Title: Innovator Spotlight: Peter Michael Wovkulich

Introduction:

Peter Michael Wovkulich, a prolific inventor with a sharp focus on pharmaceutical compounds, hails from Nutley, New Jersey, in the United States. With an impressive total of 30 patents to his name, Wovkulich has made significant contributions to the field of medicine through his groundbreaking inventions.

Latest Patents:

Wovkulich's latest patents showcase his expertise in developing novel pharmaceutical compounds. One such invention involves substituted sulfonamide compounds - a formula aimed at treating diseases mediated by TRPA1, such as pain. Another notable patent is for substituted phenylcarbamate compounds, which act as antagonists of the TRPA1 channel and show promise in treating inflammatory diseases and associated disorders.

Career Highlights:

Throughout his career, Wovkulich has demonstrated an unwavering commitment to innovation and medical advancement. He has lent his expertise to renowned companies like Hoffmann-La Roche Inc., where he has undoubtedly played a pivotal role in shaping the future of pharmaceutical research.

Collaborations:

In his quest for scientific excellence, Wovkulich has collaborated with esteemed professionals in the field. Notable coworkers include Milan R Uskokovic and Qingjie Ding, individuals who have undoubtedly enriched Wovkulich's inventive journey with their own unique insights and expertise.

Conclusion:

Peter Michael Wovkulich stands as a shining example of ingenuity and dedication in the world of pharmaceutical innovation. His numerous patents and collaborative efforts underscore his profound impact on the field, offering hope for the development of novel treatments and solutions in the realm of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…